DEXCOM, INC. Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value
DEXCOM, INC. (DXCM) reported Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value of $7.90 million for the 12-month period ending 2020-12-31, per its 10-K filed 2023-02-09.
Discontinued › Notes › Compensation Related Costs › Share-Based Payment Arrangement, Disclosure › Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Additional Disclosures
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue · last filed 2023-02-09
- DEXCOM, INC. share-based compensation arrangement by share-based payment award, options, exercises in period, intrinsic value for the quarter ending 2017-12-31 was $21.60M.
- DEXCOM, INC. share-based compensation arrangement by share-based payment award, options, exercises in period, intrinsic value for fiscal 2020 was $7.90M, a 6.76% increase from fiscal 2019.
- DEXCOM, INC. share-based compensation arrangement by share-based payment award, options, exercises in period, intrinsic value for fiscal 2019 was $7.40M, a 75.33% decline from fiscal 2018.
- DEXCOM, INC. share-based compensation arrangement by share-based payment award, options, exercises in period, intrinsic value for fiscal 2018 was $30.00M, a 38.89% increase from fiscal 2017.
- DEXCOM, INC. share-based compensation arrangement by share-based payment award, options, exercises in period, intrinsic value for fiscal 2017 was $21.60M, a 45.86% decline from fiscal 2016.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value 12 month |
|---|---|---|
| 2020-12-31 | $7.90M 10-K · filed 2023-02-09 | |
| 2019-12-31 | $7.40M 10-K · filed 2022-02-14 | |
| 2018-12-31 | $30.00M 10-K · filed 2021-02-11 | |
| 2017-12-31 | $21.60M 10-K · filed 2019-02-21 | $21.60M 10-K · filed 2020-02-13 |
| 2016-12-31 | $39.90M 10-K · filed 2019-02-21 | |
| 2015-12-31 | $125.80M 10-K · filed 2018-02-27 | |
| 2014-12-31 | $99.00M 10-K · filed 2017-02-28 | |
| 2013-12-31 | $29.80M 10-K · filed 2016-02-23 | |
| 2012-12-31 | $2.70M 10-K · filed 2015-02-25 | |
| 2011-12-31 | $3.00M 10-K · filed 2014-02-20 | |
| 2010-12-31 | $2.60M 10-K · filed 2013-02-21 | |
| 2009-12-31 | $100.00K 10-K · filed 2012-02-23 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| WEST PHARMACEUTICAL SERVICES INC (WST) | United States | $26.288B | 43.14 |
| BECTON DICKINSON & CO (BDX) | United States | $48.834B | 43.79 |
| Solventum Corp (SOLV) | United States | $15.085B | 9.16 |
| Penumbra Inc (PEN) | United States | $12.596B | 77.33 |
| BAXTER INTERNATIONAL INC (BAX) | United States | $12.139B | -10.35 |
| GLOBUS MEDICAL INC (GMED) | United States | $9.977B | 20.03 |
| INSULET CORP (PODD) | United States | $9.420B | 28.12 |
| GLAUKOS Corp (GKOS) | United States | $9.135B | -43.73 |
| MiniMed Group, Inc. (MMED) | United States | $5.748B | -16.85 |
| MERIT MEDICAL SYSTEMS INC (MMSI) | United States | $5.212B | 28.44 |